Research
Featured research
Featured research topics
GLP-1
Oncology
Flu/RSV
Measles
Cardiovascular
GLP-1 prescriptions remained elevated three months after Medicare GLP-1 Bridge launch
Understanding the real-world burden of ornithine transcarbamylase deficiency (OTCD): New insights into a rare disease
AMCP Nexus: Early uptake of oral semaglutide for obesity (Wegovy pill)
CGM use associated with lower risk of death and cardiovascular events in adults with type 2 diabetes
CGM use in adults with type 2 diabetes on basal insulin was linked to 44% lower risk of death and fewer heart attacks and strokes in…
E-bike injuries increased at a rate 100 times greater than traditional bicycle injuries through summer 2026
ED visits associated with e-bikes increased across every age group, but the increase was most pronounced among children and adolescents under 18 years, whose rate rose…
Comparing diuretic treatment strategies in heart failure hospitalization
Influenza-associated hospitalizations are rising faster early in the 2026–27 season compared to prior seasons
By the end of September, the rate of influenza-associated hospitalizations was nearly 3x higher than the next-highest rate in 6 years of data.
Rising use of robotic-assisted total knee arthroplasty
New Truveta Research shows robotic-assisted knee replacements increased from 12.4% to 36.1% between 2018 and 2026 and were associated with fewer complications.
Rising use of robotic-assisted total hip arthroplasty
Robotic-assisted hip replacement use nearly tripled from 2018 to 2026 and was associated with longer operations but lower rates of several complications.
Trends in computer-assisted navigation during endoscopic sinus surgery among US adults, 2018–2026
Prevalence and trends in acute diabetes-related complications among hospitalized patients with type 1 diabetes
Testosterone use is on the rise, and doubled in adults aged 18-34
Testosterone use increased steadily from 2018 to 2026 across all age groups. New Truveta research found prescribing among adults ages 18–34 more than doubled.